BCB Bancorp BCBP Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies
Other financials
Where this comes from
Reported directly by BCB Bancorp in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.
The official record: BCB Bancorp’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about BCB Bancorp's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BCB Bancorp's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
- BCB Bancorp (BCBP) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $8.77 in Q1 2026.
- How has BCB Bancorp's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value changed year-over-year?
- BCB Bancorp's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value decreased by 19.8% year-over-year, from $10.93 to $8.77.
- What is the long-term trend for BCB Bancorp's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
- Over 5 years (2020 to 2025), BCB Bancorp's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value has grown at a -1.8% compound annual growth rate (CAGR), from $12.46 to $11.36.